CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Brief educational videoWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D016638 Critical Illness NIH 0.14

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Study to Evaluate Health Behavior and Access Impacts Due to COVID-19 and for Community Engagement of Stakeholders Surrounding Scarce Resource Allocation Policy.

The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.

NCT04373135 Covid-19 Critical Illness Attitude of Health Personnel Attitude to Health Health Behavior Health Care Utilization Behavioral: Brief educational video
MeSH:Critical Illness

Primary Outcomes

Description: Improvement in knowledge item score of 2 points on follow up after intervention delivery and at final follow up

Measure: Improvement in knowledge surrounding SRA policy

Time: 1 month, 6 months

Description: Improvement in anxiety scale of 2 points responses on follow up after intervention delivery and at final follow up

Measure: Improvement in anxiety surrounding SRA policy

Time: 1 month, 6 months

Description: Improvement in trust scale of 2 points responses on follow up after intervention delivery and at final follow up

Measure: Improvement in trust surrounding SRA policy

Time: 1 month, 6 months


No related HPO nodes (Using clinical trials)